Prevalence of serious bacterial infections in children with sickle cell disease at king abdulaziz hospital, al ahsa
Conclusion: It appears that in the current era, less than 10% of febrile children with sickle cell disease in our center are diagnosed with a SBI. Over an 11-year period, there were no sequelae or deaths from SBI. Given these excellent outcomes, outpatient ceftriaxone should be considered for febrile well appearing children with sickle cell disease if they have no apparent source and parents are judged to be reliable.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Manal Alsaif, Joan Robinson, Moshtag Abdulbaqi, Mustafa Aghbari, Khalid Al Noaim, Muneera Alabdulqader Source Type: research
More News: Ceftriaxone | Children | Hematology | Infectious Diseases | Middle East Health | Osteomyelitis | Pneumonia | Rocephin | Saudi Arabia Health | Sickle Cell Anemia